Trial
NCT02953379
Efficacy and Safety of the Mometasone Nasal Gel in the Treatment of Persistent Allergic Rhinitis
Phase IIIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
EMS
Collaborators
—
Condition
Allergic Rhinitis
Intervention
EMS Mometasone gel
Why stopped
Sponsor decision
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-11-04